SEVEN EIGHT CAPITAL, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$389,000
-52.5%
3,900
-45.3%
0.10%
+132.6%
Q4 2019$819,000
-6.3%
7,130
+2.9%
0.04%
-6.5%
Q3 2019$874,000
-22.4%
6,930
-29.5%
0.05%
-32.4%
Q3 2018$1,126,000
-63.7%
9,830
-71.6%
0.07%
-68.5%
Q2 2018$3,106,000
-25.4%
34,630
-39.1%
0.22%
-37.0%
Q1 2018$4,163,00056,9000.34%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders